指南与共识消化、代谢与肾脏急症重症综合管理与镇静镇痛

确定适合转诊至社区药房管理的轻微病症的共识方法

Consensus methodology to determine minor ailments appropriate to be directed for management within community pharmacy.
指南 / 共识 · Res Social Adm Pharm · 2018-01-04
一句话结论利益相关者共识确定64种低 acuity 病症可经NHS111安全转诊至社区药房,2016年2–8月英格兰东北部约35,000例(占总数11.5%)可分流。

本研究通过两次共识发展利益相关者研讨会,设计并评估将NHS111低 acuity 病症患者转诊至社区药房的路径。低 acuity 病症定义为可由社区药师进行临床评估且所需治疗和/或建议在社区药房可获得的病症。利用2016年2–8月英格兰东北部回顾性NHS111患者数据及NHS Pathways临床决策支持软件,利益相关者达成共识确定64种低 acuity 病症可安全转诊至社区药房,该地区同期约35,000例患者(占总数的11.5%)可从高成本机构分流。结论认为该清单可能实现从紧急和急诊护理机构转移工作量,未来需评估成本、临床结局和患者满意度。

要点

  • 利益相关者共识确定64种低 acuity 病症可经NHS111安全转诊至社区药房。
  • 2016年2–8月英格兰东北部NHS111数据中,这些病症约35,000例(占总数的11.5%)可从高成本机构分流。
  • 低 acuity 病症定义为可由社区药师临床评估且所需治疗和/或建议在社区药房可获得的病症。
  • 共识讨论提供了病症分类的理由,以确保患者安全、护理体验和附加价值。
  • 未来需评估社区药房转诊服务的成本、临床结局和患者满意度。

适用人群与场景

  • NHS111医疗求助热线接到的低 acuity 病症患者,数据来自英格兰东北部2016年2–8月。

诊断标准与关键阈值

  • 低 acuity 病症定义为可由社区药师进行临床评估且所需治疗和/或建议在社区药房可获得的病症。
  • 利益相关者共识确定64种低 acuity 病症可安全转诊至社区药房。

处置流程与药物剂量

  • 通过NHS111路径将低 acuity 病症患者转诊至社区药房。

研究设计与关键结果

  • 研究为两次共识发展利益相关者研讨会,使用2016年2–8月英格兰东北部回顾性NHS111患者数据及NHS Pathways临床决策支持软件。
  • 利益相关者达成共识确定64种低 acuity 病症可安全转诊至社区药房。
  • 该地区2016年2–8月约35,000例患者(占总数的11.5%)可从高成本机构分流。

证据类型、等级与局限

  • 证据类型:共识发展研讨会(利益相关者共识)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,确定的低 acuity 病症清单经NHS111转诊至社区药房可能导致从紧急和急诊护理机构转移工作量。
  • 作者指出,未来工作需要评估社区药房转诊服务的成本、临床结局和患者满意度,该服务有潜力改善社区药房在更广泛NHS中的整合。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: National Health Service (NHS) 111, a medical helpline for urgent care used within the England and Scotland, receives significant numbers of patient calls yearly for a range of clinical conditions. Some are considered high acuity and mainly directed to urgent and emergency care. Low acuity conditions are also directed to these costly, overburdened services. Community pharmacy is a recognised setting for effective low acuity condition management and could offer an alternative.

OBJECTIVE: To design and evaluate a new NHS111 pathway re-directing patients with low acuity conditions to community pharmacy.

METHODS: Two consensus development stakeholder workshops were undertaken. A "low acuity" condition was defined as one that can be clinically assessed by a community pharmacist and requires a treatment and/or advice available within a community pharmacy. Retrospective NHS111 patient data (February-August 2016) from the North East of England and access to the NHS Pathways clinical decision support software were available to stakeholders. The NHS111 data demonstrated the volume of patient calls for these conditions that could have been redirected to community pharmacy.

RESULTS: Stakeholders reached consensus that 64 low acuity conditions could be safely redirected to community pharmacy via NHS111. This represented approximately 35,000 patients (11.5% of total) being shifted away from the higher cost settings in the North East region alone during February-August 2016. The stakeholder group discussions provided rationale behind their classifications of conditions to ensure patient safety, the care experience and added value.

CONCLUSIONS: The resulting definitive list of low acuity conditions that could be directed to community pharmacy via NHS111 could result in a shift of workload from urgent and emergency care settings. Future work needs to evaluate the cost, clinical outcomes, patient satisfaction of a community pharmacy referral service that has the potential to improve integration of community pharmacy in the wider NHS.

来源:Res Social Adm Pharm,查看原文。版权归原作者所有。

参考来源

  1. Nazar H, Nazar Z, Yeung A, et al. Consensus methodology to determine minor ailments appropriate to be directed for management within community pharmacy. Res Social Adm Pharm. 2018. PMID: 29310993. doi:10.1016/j.sapharm.2018.01.001

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。